The FDA has approved the first at-home brain stimulation device for treating depression. Flow Neuroscience’s FL-100 delivers ...
FRIDAY, Dec. 12, 2025 (HealthDay News) — An at-home device that sends a gentle electrical current to the brain to help treat depression has been cleared by the U.S. Food and Drug Administration (FDA).
An in-home headset that allows people with depression to send mild electrical current to their brains has been cleared by the ...
SPRAVATO is the first FDA-approved nasal spray specifically for adults with treatment-resistant depression. Available with a ...
NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, said it amended its Investigational New Drug filing for NRX-101 to include use of the drug in combination with ...
McLeod Software’s latest version of its transportation management solutions for freight brokers and motor carriers is “a completely re-engineered user interface and workflows for trucking operations,” ...
Repetitive transcranial magnetic stimulation (rTMS) and other targeted, noninvasive neuromodulation approaches offer promise for treating neuropsychiatric conditions. These techniques work by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results